Moderna Tests Lower-Dose Vaccines in Attempt to Boost Supply

Moderna may also need to expand work on boosters to cover for more variants, Chairman Noubar Afeyan said in interview with Bloomberg Television.

Coronavirus may become endemic, much like seasonal flu
Herd immunity can probably be judged only in hindsight: Afeyan
Vaccinating children seems like the better approach considering Covid’s after-effects
NOTE: Moderna to Supply Up to 500 Million Vaccine Doses to Covax

To contact the reporters on this story:
Francine Lacqua in London at flacqua@bloomberg.net;
Marthe Fourcade in Paris at mfourcade@bloomberg.net

To contact the editor responsible for this story:
Eric Pfanner at epfanner1@bloomberg.net

To read the full article log in.